Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer

This study has been completed.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Colorectal Cancer
			Metastatic Cancer
2		Additional conditions recognized in this trial
			Colorectal Neoplasms
			Neoplasm Metastasis
3		More general conditions related to this trial
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Site
			Neoplastic Processes
			Pathologic Processes
			Rectal Diseases
4		Interventions listed in this trial
			dexamethasone
			floxuridine
			irinotecan hydrochloride
			adjuvant therapy
			conventional surgery
5		Additional drug interventions recognized in this trial
			Camptothecin
			Dexamethasone acetate
			Irinotecan
6		More general drug interventions related to this trial
			Anti-Inflammatory Agents
			Antiemetics
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antineoplastic Agents, Hormonal
			Antineoplastic Agents, Phytogenic
			Autonomic Agents
			Central Nervous System Agents
			Enzyme Inhibitors
			Gastrointestinal Agents
			Glucocorticoids
			Hormones
			Hormones, Hormone Substitutes, and Hormone Antagonists
			Molecular Mechanisms of Pharmacological Action
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			Memorial Sloan-Kettering Cancer Center
			National Cancer Institute (NCI)